Long COVID's impact on patients, workers, & society: a review

KT Kavanagh, LE Cormier, C Pontus, A Bergman… - Medicine, 2024 - journals.lww.com
The incidence of long COVID in adult survivors of an acute SARS-CoV-2 infection is
approximately 11%. Of those afflicted, 26% have difficulty with day-to-day activities. The …

Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology

AG Ewing, S Salamon, E Pretorius, D Joffe, G Fox… - Medical …, 2024 - degruyter.com
Long COVID, as currently defined by the World Health Organization (WHO) and other
authorities, is a symptomatic condition that has been shown to affect an estimated 10%–30 …

Increased pediatric respiratory syncytial virus case counts following the emergence of SARS-CoV-2 can be attributed to changes in testing

BA Petros, CE Milliren, PC Sabeti… - Clinical Infectious …, 2024 - academic.oup.com
Background Respiratory syncytial virus (RSV) circulation dropped markedly early in the
COVID-19 pandemic, followed by a resurgence with heightened case counts. The “immunity …

Outbreaks of post-pandemic childhood pneumonia and the re-emergence of endemic respiratory infections

DV Parums - … science monitor: international medical journal of …, 2023 - pmc.ncbi.nlm.nih.gov
In October and November 2023, hospitals in the major cities of Bei**g and Liaoning in
northern China reported a surge in cases of pneumonia in children, with some hospitals …

[HTML][HTML] The changing landscape of respiratory viruses contributing to hospitalizations in Quebec, Canada: results from an active hospital-based surveillance study

R Gilca, R Amini, S Carazo, R Doggui… - JMIR Public Health …, 2024 - publichealth.jmir.org
Background A comprehensive description of the combined effect of SARS-CoV-2 and
respiratory viruses other than SARS-CoV-2 (ORVs) on acute respiratory infection (ARI) …

Spatial and temporal transmission dynamics of respiratory syncytial virus in New Zealand before and after the COVID-19 pandemic

L Jelley, J Douglas, M O'Neill, K Berquist… - Nature …, 2024 - nature.com
Human respiratory syncytial virus (RSV) is a major cause of acute respiratory infection. In
2020, RSV was eliminated from New Zealand due to non-pharmaceutical interventions (NPI) …

Modulation of innate immunity related genes resulting in prophylactic antimicrobial and antiviral properties

V Ferrucci, M Miceli, C Pagliuca, O Bianco… - Journal of Translational …, 2024 - Springer
Background The innate immunity acts during the early phases of infection and its failure in
response to a multilayer network of co-infections is cause of immune system dysregulation …

The Impact of COVID‐19 Pandemic on Respiratory Syncytial Virus Infection in Children

JB Trigueros Montes, D Montes, A Miele… - Pulmonary …, 2024 - Wiley Online Library
Background/Objective: Respiratory syncytial virus (RSV) is a major cause of bronchiolitis in
infants and young children. Bronchiolitis, an acute inflammation of the lower respiratory tract …

Increased pediatric RSV case counts following the emergence of SARS-CoV-2 are attributable to increased testing

BA Petros, CE Milliren, PC Sabeti, A Ozonoff - MedRxiv, 2024 - pmc.ncbi.nlm.nih.gov
Background: The incidence of respiratory syncytial virus (RSV) dropped markedly early in
the COVID-19 pandemic, followed by a resurgence with heightened case counts. The …

[HTML][HTML] Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines

C Anastassopoulou, S Medić, S Ferous, F Boufidou… - Vaccines, 2025 - mdpi.com
Respiratory syncytial virus (RSV) causes significant morbidity and mortality, especially in
young children and the elderly. RSV vaccine development puzzled vaccinologists for years …